ACL Top Analyzers – Mandatory Parameter Upgrade — recall 48705
Health Canada — Medical Devices · Canada · 2012-09-17 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: The manufacturer is conducting a mandatory parameter upgrade (P-14.8) based on two Fibrinogen-C reporting issues. Issue number one was a result of 3 customer complaints where low abnormal Fibrinogen sample reports were reporting as normal. Issue two was identified by the manufacturer during R&D where high Fibrinogen samples were reported as low.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.